MEDI 263-Discovery of the cholesteryl ester transfer protein inhibitor anacetrapib

被引：0
|
作者：
Sinclair, Peter J. [1 ]
Ali, Amjad [1 ]
Lu, Zhijian [1 ]
Smith, Cameron [1 ]
Thompson, Christopher F. [1 ]
Taylor, Gayle [1 ]
Anderson, Matt S. [2 ]
Eveland, Suzanne S. [2 ]
Hyland, Sheryl A. [2 ]
Latham, Melanie J. [3 ]
Tong, Xinchun [1 ]
Xu, Suoyu S. [1 ]
Peterson, Laurence B. [3 ]
Rosa, Ray [3 ]
Sparrow, Carl P. [2 ]
Hammond, Milton L.
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Atherosclerosis & Endocrinol, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
263-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anacetrapib, a cholesteryl ester transfer protein inhibitor
    Hooper, Amanda J.
    Burnett, John R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (01) : 103 - 109
  • [2] EFFECTS OF THE CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR ANACETRAPIB ON LIPOPROTEIN SUBFRACTIONS
    Krauss, R.
    Wojnoonski, K.
    Geaney, J. C.
    Kimberlin, R.
    Johnson-Levonas, A.
    Luk, J.
    Krishna, R.
    Wagner, J.
    Anderson, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans
    Kumar, Sanjeev
    Tan, Eugene Y.
    Hartmann, Georgy
    Biddle, Zachary
    Bergman, Arthur J.
    Dru, James
    Ho, Jonathan Z.
    Jones, Allen N.
    Staskiewicz, Steve J.
    Braun, Matthew P.
    Karanam, Bindhu
    Dean, Dennis C.
    Gendrano, Isaias Noel
    Graves, Mark W.
    Wagner, John A.
    Krishna, Rajesh
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 474 - 483
  • [4] Model-Based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor
    Rajesh Krishna
    Arthur J. Bergman
    Michele Green
    Marissa F. Dockendorf
    John A. Wagner
    Kevin Dykstra
    The AAPS Journal, 2011, 13 : 179 - 190
  • [5] Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia
    Teramoto, Tamio
    Shirakawa, Masayoshi
    Kikuchi, Masashi
    Nakagomi, Mariko
    Tamura, Satoko
    Surks, Howard K.
    Sisk, Christine McCrary
    Numaguchi, Hirotaka
    ATHEROSCLEROSIS, 2013, 230 (01) : 52 - 60
  • [6] Model-Based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor
    Krishna, Rajesh
    Bergman, Arthur J.
    Green, Michele
    Dockendorf, Marissa F.
    Wagner, John A.
    Dykstra, Kevin
    AAPS JOURNAL, 2011, 13 (02): : 179 - 190
  • [7] Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein
    Reinhard, EJ
    Wang, JL
    Durley, RC
    Fobian, YM
    Grapperhaus, ML
    Hickory, BS
    Massa, MA
    Norton, MB
    Promo, MA
    Tollefson, MB
    Vernier, WF
    Connolly, DT
    Witherbee, BJ
    Melton, MA
    Regina, KJ
    Smith, ME
    Sikorski, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (11) : 2152 - 2168
  • [8] The cholesterol ester transfer protein inhibitor, anacetrapib
    Jialal, Ishwarlal
    Kaur, Jaspreet
    CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (03) : 245 - 246
  • [9] Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study
    Gotto, Antonio M., Jr.
    Moon, Jennifer E.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (08) : 955 - 963
  • [10] Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients
    Bloomfield, Daniel
    Carlson, Gary L.
    Sapre, Aditi
    Tribble, Diane
    McKenney, James M.
    Littlejohn, Thomas W., III
    Sisk, Christine McCrary
    Mitchel, Yale
    Pasternak, Richard C.
    AMERICAN HEART JOURNAL, 2009, 157 (02) : 352 - U20
12345